J.P. Morgan Healthcare Conference
Burrill Capital Fund IV Takes on Foreign Flavor
By Marie Powers
Wednesday, January 18, 2012
SAN FRANCISCO Although most of the biotech world was starting last week with a J.P. Morgan Healthcare Conference hangover, it was business as usual for the redoubtable Steve Burrill, whose life sciences venture firm, Burrill & Co., recently added Capital Fund IV to its portfolio.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.